首页> 外文期刊>Artificial cells, nanomedicine, and biotechnology. >Inhalable chitosan nanoparticles as antitubercular drug carriers for an effective treatment of tuberculosis
【24h】

Inhalable chitosan nanoparticles as antitubercular drug carriers for an effective treatment of tuberculosis

机译:可吸入的壳聚糖纳米颗粒作为抗结核药物载体,可有效治疗肺结核

获取原文
获取原文并翻译 | 示例
       

摘要

The aim of this study was to prepare and characterize spray dried inhalable chitosan nanoparticles (CNPs) for sustained delivery of anti-tubercular drugs, isoniazid (INH) and rifampicin (RIF), to the lungs. CNPs were prepared by ionic gelation technique followed spray drying. Results showed that the CNPs obtained had a smooth spherical shape with an average size of 230 +/- 4.5 nm, with a poly dispersity index of 0.180 +/- 0.021. Both drugs, were detected in various organs (lungs, liver, spleen and kidney) until 24 h post nebulization. The chemotherapeutic efficacy of a single dose of drug-loaded CNPs suggested that they are more effective against the mycobacterium than free drugs.
机译:这项研究的目的是制备和表征喷雾干燥的可吸入壳聚糖纳米颗粒(CNP),以将抗结核药异烟肼(INH)和利福平(RIF)持续输送到肺部。 CNP通过离子凝胶技术随后喷雾干燥制备。结果表明,所获得的CNP具有光滑的球形形状,平均尺寸为230 +/- 4.5nm,多分散指数为0.180 +/- 0.021。直到雾化后24小时,在各种器官(肺,肝,脾和肾)中都检测到这两种药物。单剂量载药的CNP的化学治疗功效表明,它们比游离药物对分枝杆菌更有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号